Shares of Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) dropped 5.8% on Monday . The company traded as low as $0.78 and last traded at $0.81. Approximately 17,735 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 276,427 shares. The stock had previously closed at $0.86. Evaxion […]
Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report)’s share price fell 5.8% on Monday . The company traded as low as $0.78 and last traded at $0.81. 17,735 shares changed hands during mid-day trading, a decline of 94% from the average session volume of 276,427 shares. The stock had previously closed at $0.86. Evaxion Biotech […]
Form 6-K Evaxion Biotech A/S For: Nov 28 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Proof of Concept – Evaxion’s AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cancers by targeting a.
Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.